Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of bimatoprost 0.01% for the treatment of eyebrow hypotrichosis
TCTR20160911001Phase 3Completed
- Sponsor
- Division of Dermatology, Ramathibodi Hospital, Mahidol University
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bimatoprost in Eyebrow hypotrichosis, sponsored by Division of Dermatology, Ramathibodi Hospital, Mahidol University. Started Jul 2016; status: completed.
02
Drugs
bimatoprost
03
Conditions
Eyebrow hypotrichosis
Beyond the preview
Go deeper on TCTR20160911001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160911001.